List of Suppliers of Butofilolol intermediates listed on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Cafide, 58930-32-8, 64552-17-6, 1-[2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-5-fluorophenyl]-1-butanone, Butofilolol [inn], Cm-6805
Molecular Formula
C17H26FNO3
Molecular Weight
311.4  g/mol
InChI Key
NMBNQRJDEPOXCP-UHFFFAOYSA-N
FDA UNII
4AZC6Y5A8G

Butofilolol
1 2D Structure

Butofilolol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one
2.1.2 InChI
InChI=1S/C17H26FNO3/c1-5-6-15(21)14-9-12(18)7-8-16(14)22-11-13(20)10-19-17(2,3)4/h7-9,13,19-20H,5-6,10-11H2,1-4H3
2.1.3 InChI Key
NMBNQRJDEPOXCP-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCC(=O)C1=C(C=CC(=C1)F)OCC(CNC(C)(C)C)O
2.2 Other Identifiers
2.2.1 UNII
4AZC6Y5A8G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Butofilolol, (+-)-isomer

2. Cafide

3. Cm 6805

4. Cm-6805

2.3.2 Depositor-Supplied Synonyms

1. Cafide

2. 58930-32-8

3. 64552-17-6

4. 1-[2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-5-fluorophenyl]-1-butanone

5. Butofilolol [inn]

6. Cm-6805

7. 4azc6y5a8g

8. 1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one

9. 1-(2-(3-(tert-butylamino)-2-hydroxypropoxy)-5-fluorophenyl)butan-1-one

10. (+/-)-2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorobutyrophenone

11. 2'-(3-(tert-butylamino)-2-hydroxypropoxy)-5'-fluorobutyrophenone

12. 1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl}butan-1-one

13. 1-butanone, 1-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-fluorophenyl)-

14. Unii-4azc6y5a8g

15. Butofilololum [inn-latin]

16. Einecs 261-502-5

17. Cm 6805

18. Butofilolol [mi]

19. Butofilolol [mart.]

20. Schembl78268

21. Chembl157443

22. Dtxsid30867082

23. Chebi:135327

24. Bbl101859

25. Mfcd00864575

26. Stl555656

27. Akos007930875

28. Hy-w096097

29. As-73617

30. Cs-0147735

31. L013404

32. Sr-01000945082

33. Q5002736

34. Sr-01000945082-1

35. 1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl}-1-butanone

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 311.4 g/mol
Molecular Formula C17H26FNO3
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count9
Exact Mass311.18967185 g/mol
Monoisotopic Mass311.18967185 g/mol
Topological Polar Surface Area58.6 Ų
Heavy Atom Count22
Formal Charge0
Complexity343
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adrenergic beta-Antagonists

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty